Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Talon Therapeutics Looks Undervalued Following FDA's Surprise Early Approval
Talon Therapeutics Looks Undervalued Following FDA's Surprise Early Approval
Talon Therapeutics Looks Undervalued Following FDA's Surprise Early Approval
Submitted by
admin
on August 10, 2012 - 10:02am
Source:
Yahoo/Reuters
News Tags:
Talon Therapeutics
FDA
acute lymphoblastic leukemia
Marqibo
Headline:
Talon Therapeutics Looks Undervalued Following FDA's Surprise Early Approval
Do Not Allow Advertisers to Use My Personal information
